{"id":"W2808040186","doi":"10.1200/jco.2017.35.15_suppl.tps4590","title":"Phase 3 KEYNOTE-361 trial: Pembrolizumab (pembro) with or without chemotherapy versus chemotherapy alone in advanced urothelial cancer.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"ca_institutions":"Moncton Hospital","funders":"","keywords":"Gemcitabine; Medicine; Chemotherapy; Carboplatin; Urothelial cancer; Cisplatin; Pembrolizumab; Oncology; Docetaxel; Bladder cancer; Metastatic Urothelial Carcinoma; Internal medicine; Cancer; Urothelial carcinoma; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002307681,0.002429271,0.002540508,0.0004787587,0.0005616233,0.001572366,0.001452535,0.002442521,0.01443078],"category_scores_gemma":[0.001596697,0.0007570598,0.002325738,0.0005061557,0.001016065,0.001675246,0.0005954794,0.005130632,0.002650931],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001396047,"about_ca_system_score_gemma":0.00175821,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001143005,"about_ca_topic_score_gemma":0.002776231,"domain_scores_codex":[0.9994492,0.0002732009,0.00002526328,0.0001050175,0.00004456983,0.0001027586],"domain_scores_gemma":[0.9992964,0.0001179857,0.0002061,0.00005166625,0.00003865036,0.0002891739],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9660592,0.007951922,0.0004321657,0.00104649,0.0006411159,0.00005342233,0.0000567783,0.0006309934,0.00391771,0.0002323594,0.003368231,0.01560962],"study_design_scores_gemma":[0.9309964,0.06470434,0.001305332,0.00005929421,0.0003062697,0.00007251374,0.00001801223,0.0004536591,0.0004352272,0.0002910752,0.001343815,0.00001396016],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9444814,0.01039487,0.001483011,0.003496131,0.001489586,0.01789442,0.009921744,0.000669626,0.01016927],"genre_scores_gemma":[0.952032,0.004608359,0.003153391,0.004205917,0.0007288097,0.0164243,0.006753515,0.0001073191,0.01198644],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01443078,"threshold_uncertainty_score":0.04827583,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1709571782320348,"score_gpt":0.5346557741687141,"score_spread":0.3636985959366793,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}